Early results from Russia’s COVID-19 vaccine showed no negative side effects, a study published in the peer-reviewed medical journal, The Lancet revealed just moments ago.
“Preliminary results from Russian trials find that COVID19 vaccine candidates led to no serious adverse events and elicit an antibody response,” a tweet from the journal’s Twitter account read.
READ: Covid-19: Unilever Nigeria suffers 40% revenue loss
READ ALSO: COVID-19: 25 million will be jobless, as Recession looms
NEW—Preliminary results from Russian trials find that #COVID19 vaccine candidates led to no serious adverse events and elicit antibody response https://t.co/jGUwQa8oNd
Thread (1/8) pic.twitter.com/NWBpWDvUK3
— The Lancet (@TheLancet) September 4, 2020
What we know; In Phase 1 and 2 studies of the vaccine, which is named Sputnik V, all 76 study participants developed antibodies to the virus that causes Covid-19, according to Friday’s report in The Lancet.
Explore financial calculators on Nairametrics
The levels of neutralizing antibody response were similar to the immune response that people had after naturally recovering from Covid-19, according to the study.
The medical researchers also observed the responses from T cells, another component of the immune system.”[Outcomes from] the trial also suggest the vaccines also produce a T cell response within 28 days,” the researchers wrote.
